scholarly journals Legionnaires’ Disease Presenting with Exanthem; Case and Review of Previously Published Cases

IDCases ◽  
2022 ◽  
pp. e01376
Author(s):  
Christine J Carter ◽  
Elizabeth M Corley ◽  
Hannah Canepa ◽  
Sarah A Schmalzle
Keyword(s):  
Legionnaires Disease

Analytical Methods Practiced to Quantitation of Rifampicin: A Captious Survey

2020 ◽  
Vol 16 ◽  
Author(s):  
Rajendra Muljibhai Kotadiya ◽  
Foram Narottambhai Patel
Keyword(s):  
Thin Layer ◽  
Thin Layer Chromatography ◽  
Analytical Methods ◽  
Bacterial Infections ◽  
High Performance ◽  
Drug Product ◽  
Extensive Literature ◽  
Legionnaires Disease ◽  
Instrumental Methods ◽  
Layer Chromatography

Background: Rifampicin (RIF), also known as rifampin, a bactericidal antibiotic having broad antibacterial activity against various gram-positive and gram-negative bacteria act by inhibiting DNA dependent RNA polymerase. RIF has been administered in different dosage forms like tablets, capsules, injections, oral suspension, powder etc. for the treatment of several types of bacterial infections, including tuberculosis, Mycobacterium avium complex, leprosy and Legionnaires’ disease. Introduction: To ensure the quality, efficacy, safety and effectiveness of RIF drug product, effective and reliable analytical methods are utmost important. To quantify RIF for quality control or pharmacokinetic purposes, alternative analytical methods have been developed along with the official compendial methods. Method: In this review paper, an extensive literature survey was done to gather information on various analytical instrumental methods used so far for RIF. Result: These methods were high-performance liquid chromatography (42%), hyphenated techniques (18%), spectroscopy (15%), high-performance thin-layer chromatography or thin-layer chromatography (7%) and miscellaneous (18%). Conclusion: All these methods were selective and specific for the RIF analysis.

scholarly journals A Legionnaires’ Disease Cluster in a Private Building in Italy

2021 ◽  
Vol 18 (13) ◽  
pp. 6922
Author(s):  
Maria Luisa Ricci ◽  
Maria Cristina Rota ◽  
Maria Grazia Caporali ◽  
Antonietta Girolamo ◽  
Maria Scaturro
Keyword(s):  
Severe Pneumonia ◽  
Control Measures ◽  
Health Concern ◽  
Human Consumption ◽  
Domestic Water ◽  
Quality Of Water ◽  
Legionnaires Disease ◽  
Prevention And Control Measures ◽  
Private Homes ◽  
And Control

Legionnaires’ disease (LD) is a severe pneumonia caused by bacteria belonging to the genus Legionella. This is a major public health concern and infections are steadily increasing worldwide. Several sources of infection have been identified, but they have not always been linked to human isolates by molecular match. The well-known Legionella contamination of private homes has rarely been associated with the acquisition of the disease, although some patients never left their homes during the incubation period. This study demonstrated by genomic matching between clinical and environmental Legionella isolates that the source of an LD cluster was a private building. Monoclonal antibodies and sequence-based typing were used to type the isolates, and the results clearly demonstrated the molecular relationship between the strains highlighting the risk of contracting LD at home. To contain this risk, the new European directive on the quality of water intended for human consumption has introduced for the first time Legionella as a microbiological parameter to be investigated in domestic water systems. This should lead to a greater attention to prevention and control measures for domestic Legionella contamination and, consequently, to a possible reduction in community acquired LD cases.

Legionnaires’ disease in a renal transplant recipient

1984 ◽  
Vol 141 (4) ◽  
pp. 241-242
Author(s):  
David C. H. Harris ◽  
Robert Chiew ◽  
Colin MacLeod
Keyword(s):  
Renal Transplant ◽  
Transplant Recipient ◽  
Renal Transplant Recipient ◽  
Legionnaires Disease

Pulmonary Fibrosis following Pneumonia Due to Acute Legionnaires’ Disease

CHEST Journal ◽  
1987 ◽  
Vol 91 (1) ◽  
pp. 57-62 ◽  
Author(s):  
Jean Chastre ◽  
Ganesh Raghu ◽  
Paul Soler ◽  
Patrick Brun ◽  
Françoise Basset ◽  
...  
Keyword(s):  
Pulmonary Fibrosis ◽  
Legionnaires Disease

Potable water as a source of legionnaires' disease

1985 ◽  
Vol 13 (6) ◽  
pp. 286 ◽  
Author(s):  
K.N. Shands ◽  
J.L. Ho ◽  
R.D. Meyer ◽  
G.W. Gorman
Keyword(s):  
Potable Water ◽  
Legionnaires Disease

scholarly journals Efficacy of SCH27899 in an Animal Model of Legionnaires' Disease Using Immunocompromised A/J Mice

2000 ◽  
Vol 44 (5) ◽  
pp. 1333-1336 ◽  
Author(s):  
Joan K. Brieland ◽  
David Loebenberg ◽  
Fred Menzel ◽  
Roberta S. Hare
Keyword(s):  
Animal Model ◽  
Murine Model ◽  
Legionella Pneumophila ◽  
Immunocompromised Host ◽  
Lung Infection ◽  
Cortisone Acetate ◽  
Contrast Administration ◽  
Once Daily ◽  
Legionnaires Disease ◽  
Lung Infections

ABSTRACT The efficacy of SCH27899, a new everninomicin antibiotic, against replicative Legionella pneumophila lung infections in an immunocompromised host was evaluated using a murine model of Legionnaires' disease. A/J mice were immunocompromised with cortisone acetate and inoculated intratracheally with L. pneumophilaserogroup 1 (105 CFU per mouse). At 24 h postinoculation, mice were administered either SCH27899 (6 to 60 mg/kg [MPK] intravenously) or a placebo once daily for 5 days, and mortality and intrapulmonary growth of L. pneumophila were assessed. In the absence of SCH27899, there was 100% mortality inL. pneumophila-infected mice, with exponential intrapulmonary growth of the bacteria. In contrast, administration of SCH27899 at a dose of ≥30 MPK resulted in ≥90% survival of infected mice, which was associated with inhibition of intrapulmonary growth ofL. pneumophila. In subsequent studies, the efficacy of SCH27899 was compared to ofloxacin (OFX) and azithromycin (AZI). Administration of SCH27899, OFX, or AZI at a dose of ≥30 MPK once daily for 5 days resulted in ≥85% survival of infected mice and inhibition of intrapulmonary growth of the bacteria. However, L. pneumophila CFU were recovered in lung homogenates following cessation of therapy with all three antibiotics. These studies demonstrate that SCH27899 effectively prevents fatal replicativeL. pneumophila lung infection in immunocompromised A/J mice by inhibition of intrapulmonary growth of the bacteria. However, in this murine model of pulmonary legionellosis, SCH27899, like OFX and AZI, was bacteriostatic.

Sign in / Sign up

Export Citation Format

Share Document